Emerging trends in female permanent contraception

Expert Review of Obstetrics and Gynecology

Volumn 8, Issue 3, 2013, Pages 285-294

  Vancaillie, Thierry G ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

female permanent contraception; hysteroscopic sterilization; quality of life

Indexed keywords

LEVONORGESTREL; MEPACRINE; ORAL CONTRACEPTIVE AGENT;

ACNE; CESAREAN SECTION; CONTRACEPTION; CULTURAL FACTOR; ECTOPIC PREGNANCY; ENDOMETRIUM ABLATION; FAMILY PLANNING; FEMALE PERMANENT CONTRACEPTION; FEMALE STERILIZATION; FERTILIZATION IN VITRO; HORMONAL CONTRACEPTION; HUMAN; HYDROSALPINX; HYSTEROSCOPE; HYSTEROSCOPY; INSTRUMENT STERILIZATION; INTRAUTERINE CONTRACEPTIVE DEVICE; LAPAROSCOPY; OVARY POLYCYSTIC DISEASE; QUALITY OF LIFE; RELIGION; REVIEW; SOCIOECONOMICS; UTERINE TUBE LIGATION; UTERINE TUBE OCCLUSION;

EID: 84877273781     PISSN: 17474108     EISSN: 17474116     Source Type: Journal    
DOI: 10.1586/eog.13.17     Document Type: Review

References (104)

1. Crawford MH. Roman Statutes Bulletin of the Institute of Classical Studies. University of London, London, UK, 801-809 (1996).
2. Wang C. History of the Chinese Family Planning program: 1970-2010. Contraception 85(6), 563-569 (2012).
3. The Holy See. Acta Pauli PP VI. Acta Apostolica Sedis LX, 481-503 (1968).
4. Mecklenburg M, Fink JP; ACCL Education Fund. All About Families: Research in Progress on Education for Parenthood, Abortion, Family Planning, and Population Control. Life Concerns Educational Series. American Citizens Concerned for Life, Education Fund, MN, USA (1975).
5. Kuroki LM, Allsworth JE, Redding CA, Blume JD, Peipert JF. Is a previous unplanned pregnancy a risk factor for a subsequent unplanned pregnancy? Am. J. Obstet. Gynecol. 199(5), 517.e1-517.e7 (2008).
6. Wu J, Meldrum S, Dozier A, Stanwood N, Fiscella K. Contraceptive nonuse among US women at risk for unplanned pregnancy. Contraception 78(4), 284-289 (2008).
7. Bajos N, Leridon H, Goulard H, Oustry P, Job-Spira N; COCON Group. Contra-ception: from accessibility to efficiency. Hum. Reprod. 18(5), 994-999 (2003).
8. Webb S, Holman D. A survey of contraceptive use and unplanned pregnancy in Perth, western Australia. Aust. J. Public Health 16(4), 382-386 (1992).
9. Fraser IS, Parke S, Mellinger U, Machlitt A, Serrani M, Jensen J. Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest. Eur. J. Contracept. Reprod. Health Care 16(4), 258-269 (2011).
10. Ibáñez L, De Zegher F. Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception. J. Clin. Endocrinol. Metab. 88(10), 4720-4724 (2003).
11. ESHRE Capri Workshop Group. Female contraception over 40. Hum Reprod. Update 15(6), 599-612 (2009).
12. Zipper J, Stacchetti E, Medel M. Transvaginal chemical sterilization: clinical use of quinacrine plus potentiating adjuvants. Contraception 12(1), 11-21 (1975).
13. Jensen JT, Rodriguez MI, Liechtenstein-Zábrák J, Zalanyi S. Transcervical polidocanol as a nonsurgical method of female sterilization: a pilot study. Contraception 70(2), 111-115 (2004).
14. Zaneveld LJ, Goldsmith A. Lack of tubal occlusion by intrauterine quinacrine and tetracycline in the primate. Contraception 30(2), 161-167 (1984).
15. Richart RM, Neuwirth RS, Goldsmith A, Edelman DA. Intrauterine administration of methyl cyanoacrylate as an outpatient method of permanent female sterilization. Am. J. Obstet. Gynecol. 156(4), 981-987 (1987).
16. Sokal DC, Zipper J, Guzman-Serani R, Aldrich TE. Cancer risk among women sterilized with transcervical quinacrine hydrochloride pellets, 1977 to 1991. Fertil. Steril. 64(2), 325-334 (1995).
17. Feldblum PJ, Hays M, Zipper J, Guzman-Serani R, Sokal DC. Pregnancy rates among Chilean women who had nonsurgical sterilization with quinacrine pellets between 1977 and 1989. Contraception 61(6), 379-384 (2000).
18. Benagiano G. Non-surgical female sterilization with quinacrine: an update. Contraception 63(5), 239-245 (2001).
19. Laros RK, Work BA. Female sterilization. II. A comparison of methods. Obstet. Gynecol. 46(2), 215-220 (1975).
20. Bledin KD, Cooper JE, Mackenzie S, Brice B. Psychological sequelae of female sterilization: short-term outcome in a prospective controlled study. A report from the UK Field Research Centre of a WHO collaborative project. Psychol. Med. 14(2), 379-390 (1984).
21. Cooper JE, Bledin KD, Brice B, Mackenzie S. Effects of female sterilization: one year follow-up in a prospective controlled study of psychological and psychiatric outcome. J. Psychosom. Res. 29(1), 13-22 (1985).
22. Jamieson DJ, Kaufman SC, Costello C, Hillis SD, Marchbanks PA, Peterson HB; US Collaborative Review of Sterilization Working Group. A comparison of women's regret after vasectomy versus tubal sterilization. Obstet. Gynecol. 99(6), 1073-1079 (2002).
23. Dassenaike GS, Saha A, McCann MF. Female sterilization via minilaparotomy. J. Reprod. Med. 17(2), 119-124 (1976).
24. World Health Organization, Task Force on Female Sterilization, Special Programme of Research, Development and Research Training in Human Reproduction. Minilaparotomy or laparoscopy for sterilization: a multicenter, multinational randomized study. Am. J. Obstet. Gynecol. 143(6), 645-652 (1982).
25. Ruminjo JK, Lynam PF. A fifteen-year review of female sterilization by minilaparotomy under local anesthesia in Kenya. Contraception 55(4), 249-260 (1997).
26. Mutihir JT, Nyango DD. Quarter of a century of female sterilization in Jos, Central Nigeria. Afr. J. Reprod. Health 15(1), 103-108 (2011).
27. Berger GS, Keith L. Culdotomy for female sterilization. Int. Surg. 62(2), 72-75 (1977).
28. Laros RK Jr, Work BA Jr. Female sterilization. III. Vaginal hysterectomy. Am. J. Obstet. Gynecol. 122(6), 693-697 (1975).
29. Steptoe PC. Female sterilization. Nurs. Times 67(49), 1529-1530 (1971).
30. Peterson HB, Ory HW, Greenspan JR, Tyler CW Jr. Deaths associated with laparoscopic sterilization by unipolar electrocoagulating devices, 1978 and 1979. Am. J. Obstet. Gynecol. 139(2), 141-143 (1981).
31. Kleppinger RK. Female outpatient sterilization using bipolar coagulation. Bull. Postgrad. Comm. Med. Univ. Syd. 33(8), 144-154 (1977).
32. Makar AP, Vanderheyden JS, Schatteman EA, Albertyn GP, Verkinderen JJ, Van Marck EA. Female sterilization failure after bipolar electrocoagulation: a 6 year retrospective study. Eur. J. Obstet. Gynecol. Reprod. Biol. 37(3), 237-246 (1990).
33. Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J. The risk of pregnancy after tubal sterilization: findings from the US Collaborative Review of Sterilization. Am. J. Obstet. Gynecol. 174(4), 1161-1168; discussion 1168 (1996).
34. Yoon IB, Wheeless CR Jr, King TM. A preliminary report on a new laparoscopic sterilization approach: the silicone rubber band technique. Am. J. Obstet. Gynecol. 120(1), 132-136 (1974).
35. Hulka JF, Fishburne JI, Mercer JP, Omran KF. Laparoscopic sterilization with a spring clip: a report of the first fifty cases. Am. J. Obstet. Gynecol. 116(5), 715-718 (1973).
36. Filshie GM, Casey D, Pogmore JR, Dutton AG, Symonds EM, Peake AB. The titanium/silicone rubber clip for female sterilization. Br. J. Obstet. Gynaecol. 88(6), 655-662 (1981).
37. Lawrie TA, Nardin JM, Kulier R, Boulvain M. Techniques for the interruption of tubal patency for female sterilisation. Cochrane Database Syst. Rev. 4, CD003034 (2002).
38. Peterson HB, Xia Z, Wilcox LS, Tylor LR, Trussell J; US Collaborative Review of Sterilization Working Group. Pregnancy after tubal sterilization with silicone rubber band and spring clip application. Obstet. Gynecol. 97(2), 205-210 (2001).
39. Nitze H. Ueber eine Neue Behandlungs-Methode der Hoehlen des Menschlichen Koerpers. Med. Press, Wien, Austria (1879).
40. Mikulicz-Radecki FV, Freund A. [A new hysteroscope and its practical use in gynecology]. Z. Geburtshilfe Gynakol. 92, 13-25 (1928).
41. Lindemann HJ. [Methods of sterilization of the female. Possibilities of hysteroscopic sterilization]. MMW Munch. Med. Wochenschr. 118(28), 903-906 (1976).
42. Quinones R, Alvarado A, Ley E. Hysteroscopic sterilization. Int. J. Gynaecol. Obstet. 14(1), 27-34 (1976).
43. Richart RM, Neuwirth RS, Israngkun C, Phaosavasdi S. Female sterilization by electrocoagulation of tubal ostia using hysteroscopy. Am. J. Obstet. Gynecol. 117(6), 801-804 (1973).
44. Brumsted JR, Shirk G, Soderling MJ, Reed T. Attempted transcervical occlusion of the fallopian tube with the Nd:YAG laser. Obstet. Gynecol. 77(2), 327-328 (1991).
45. Hamou J, Gasparri F, Scarselli GF et al. Hysteroscopic reversible tubal sterilization. Acta Eur. Fertil. 15(2), 123-129 (1984).
46. Sugimoto O, Oshima M. [Current and future status of hysteroscopy]. Sanfujinka No Jissai. 21(5), 377-386 (1972).
47. Brundin J. Transcervical sterilization in the human female by hysteroscopic application of hydrogelic occlusive devices into the intramural parts of the fallopian tubes: years experience of the P-block. Eur. J. Obstet. Gynecol. Reprod. Biol. 39(1), 41-49 (1991).
48. Reed TP 3rd. Ovabloc. Five years of experience. J. Reprod. Med. 29(8), 601-602 (1984).
49. Ligt-Veneman NG, Tinga DJ, Kragt H, Brandsma G, van der Leij G. The efficacy of intratubal silicone in the Ovabloc hysteroscopic method of sterilization. Acta Obstet. Gynecol. Scand. 78(9), 824-825 (1999).
50. Kerin JF, Carignan CS, Cher D. The safety and effectiveness of a new hysteroscopic method for permanent birth control: results of the first Essure pbc clinical study. Aust. N. Z. J. Obstet. Gynaecol. 41(4), 364-370 (2001).
51. Cooper JM. Hysteroscopic sterilization. Clin. Obstet. Gynecol. 35(2), 282-298 (1992).
52. Kerin JF, Munday DN, Ritossa MG, Pesce A, Rosen D. Essure hysteroscopic sterilization: results based on utilizing a new coil catheter delivery system. J. Am. Assoc. Gynecol. Laparosc. 11(3), 388-393 (2004).
53. Miño M, Arjona JE, Cordón J, Pelegrin B, Povedano B, Chacon E. Success rate and patient satisfaction with the Essure sterilisation in an outpatient setting: a prospective study of 857 women. BJOG 114(6), 763-766 (2007).
54. Vancaillie TG, Harrington DC, Anderson JM. Mechanism of action of the Adiana® device: a histologic perspective. Contraception 84(3), 299-301 (2011).
55. Herbst SJ, Evantash EG. Clinical performance characteristics of the Adiana® System for permanent contraception: the first year of commercial use. Rev. Obstet. Gynecol. 3(4), 156-162 (2010).
56. Anderson TL, Vancaillie TG. The Adiana System for permanent contraception: safety and efficacy at 3 years. J. Minim. Invasive Gynecol. 18(5), 612-616 (2011).
57. Smith RD. Contemporary hysteroscopic methods for female sterilization. Int. J. Gynaecol. Obstet. 108(1), 79-84 (2010).
58. Cleary TP, Tepper NK, Cwiak C et al. Pregnancies after hysteroscopic sterilization: a systematic review. Contraception doi:10.1016/j.contraception. 2012.08.006 (2012) (Epub ahead of print).
59. Kraemer DF, Yen PY, Nichols M. An economic comparison of female sterilization of hysteroscopic tubal occlusion with laparoscopic bilateral tubal ligation. Contraception 80(3), 254-260 (2009).
60. Povedano B, Arjona JE, Velasco E, Monserrat JA, Lorente J, Castelo-Branco C. Complications of hysteroscopic Essure® sterilisation: report on 4306 procedures performed in a single centre. BJOG 119(7), 795-799 (2012).
61. Lazarus E, Lourenco AP, Casper S, Allen RH. Necessity of hysterosalpingography after Essure microinsert placement for contraception. AJR Am. J. Roentgenol. 198(6), 1460-1463 (2012).
62. Mahmoud MS, Fridman D, Merhi ZO. Subserosal misplacement of Essure device manifested by late-onset acute pelvic pain. Fertil. Steril. 92(6), 2038.e1-2038.e3 (2009).
63. Jansen NE, Vleugels MP, Kluivers KB, Vierhout ME. Bilateral cornual abscess after endometrial ablation following Essure sterilization. J. Minim. Invasive Gynecol. 14(4), 509-511 (2007).
64. Solt I, Ioffe Y, Elmore RG, Solnik MJ. Group A streptococcal peritonitis and ruptured tubo-ovarian abscess three years after Essure® insertion: a case report. J. Womens. Health (Larchmt) 20(5), 781-783 (2011).
65. Belotte J, Shavell VI, Awonuga AO, Diamond MP, Berman JM, Yancy AF. Small bowel obstruction subsequent to Essure microinsert sterilization: a case report. Fertil. Steril. 96(1), e4-e6 (2011).
66. Moawad N, Mansuria S. Essure perforation and chronic pelvic pain. J. Minim. Invasive Gynecol. 18(3), 285-286 (2011).
67. Zurawin RK, Zurawin JL. Adverse events due to suspected nickel hypersensitivity in patients with essure micro-inserts. J. Minim. Invasive Gynecol. 18(4), 475-482 (2011).
68. Adesiyun AG. Female sterilization by tubal ligation: a re-appraisal of factors influencing decision making in a tropical setting. Arch. Gynecol. Obstet. 275(4), 241-244 (2007).
69. da Costa Leite I, Gupta N, do Nascimento Rodrigues R. Female sterilization in Latin America: cross-national perspectives. J. Biosoc. Sci. 36(6), 683-698 (2004).
70. Yang Z, Gaydos LM. Reasons for and challenges of recent increases in teen birth rates: a study of family planning service policies and demographic changes at the state level. J. Adolesc. Health 46(6), 517-524 (2010).
71. Chen ZE, Glasier A, Warner P. Why are rates of sterilization in decline? A pilot study designed to explore reasons for declining female sterilization in Scotland. Contraception 78(4), 309-314 (2008).
72. French RS, Cowan FM, Mansour D et al. Levonorgestrel-releasing (20 microgram/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives. BJOG 107(10), 1218-1225 (2000).
73. Gemzell-Danielsson K, Schellschmidt I, Apter D. A randomized, Phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrelreleasing intrauterine contraceptive systems and Mirena. Fertil. Steril. 97(3), 616-622; e1-e3 (2012).
74. Mishtal J, Dannefer R. Reconciling religious identity and reproductive practices: the Church and contraception in Poland. Eur. J. Contracept. Reprod. Health Care 15(4), 232-242 (2010).
75. Schenker JG, Rabenou V. Contraception: traditional and religious attitudes. Eur. J. Obstet. Gynecol. Reprod. Biol. 49(1-2), 15-18 (1993).
76. Atighetchi D. The position of Islamic tradition on contraception. Med. Law 13(7-8), 717-725 (1994).
77. Srikanthan A, Reid RL. Religious and cultural influences on contraception. J. Obstet. Gynaecol. Can. 30(2), 129-137 (2008).
78. Lawrence RE, Rasinski KA, Yoon JD, Curlin FA. Factors influencing physicians' advice about female sterilization in USA: a national survey. Hum. Reprod. 26(1), 106-111 (2011).
79. Diaz J, Bahamondes L, Monteiro I, Petta C, Hildalgo MM, Arce XE. Acceptability and performance of the levonorgestrelreleasing intrauterine system (Mirena) in Campinas, Brazil. Contraception 62(2), 59-61 (2000).
80. Dubuisson JB, Mugnier E. Acceptability of the levonorgestrel-releasing intrauterine system after discontinuation of previous contraception: results of a French clinical study in women aged 35 to 45 years. Contraception 66(2), 121-128 (2002).
81. Elovainio M, Teperi J, Aalto AM et al. Depressive symptoms as predictors of discontinuation of treatment of menorrhagia by levonorgestrel-releasing intrauterine system. Int. J. Behav. Med. 14(2), 70-75 (2007).
82. Shavell VI, Abdallah ME, Shade GH Jr, Diamond MP, Berman JM. Trends in sterilization since the introduction of Essure hysteroscopic sterilization. J. Minim. Invasive Gynecol. 16(1), 22-27 (2009).
83. ESHRE Capri Workshop Group. Family planning 2011: better use of existing methods, new strategies and more informed choices for female contraception. Hum Reprod. Update 18(6), 670-681 (2012).
84. Valle RF, Valdez J, Wright TC, Kenney M. Concomitant Essure tubal sterilization and Thermachoice endometrial ablation: feasibility and safety. Fertil. Steril. 86(1), 152-158 (2006).
85. Mircea CN, Goojha C, Thiel JA. Concomitant NovaSure endometrial ablation and Essure tubal sterilization: a review of 100 cases. J. Obstet. Gynaecol. Can. 33(4), 361-366 (2011).
86. Cibula D, Widschwendter M, Májek O, Dusek L. Tubal ligation and the risk of ovarian cancer: review and meta-analysis. Hum. Reprod. Update 17(1), 55-67 (2011).
87. Larsen KE, Kaalund Jensen H. Laparoscopic sterilization with the Falope-ring. Peroperative and late complications, method safety and a randomized investigation of immediate postoperative abdominal pain. Acta Obstet. Gynecol. Scand. 62(2), 125-130 (1983).
88. Kerin JF, Cattanach S. Successful pregnancy outcome with the use of in vitro fertilization after Essure hysteroscopic sterilization. Fertil. Steril. 87(5), 1212.e1-1212.e4 (2007).
89. Galen DI, Khan N, Richter KS. Essure multicenter off-label treatment for hydrosalpinx before in vitro fertilization. J. Minim. Invasive Gynecol. 18(3), 338-342 (2011).
90. Mijatovic V, Dreyer K, Emanuel MH, Schats R, Hompes PG. Essure® hydrosalpinx occlusion prior to IVF-ET as an alternative to laparoscopic salpingectomy. Eur. J. Obstet. Gynecol. Reprod. Biol. 161(1), 42-45 (2012).
91. Peterson HB, d'Arcangues C, Haidar J et al. Accelerating science-driven solutions to challenges in global reproductive health: a new framework for moving forward. Obstet. Gynecol. 117(3), 720-726 (2011).
92. Curtis KM, Mohllajee AP, Peterson HB. Regret following female sterilization at a young age: a systematic review. Contraception 73(2), 205-210 (2006).
93. Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J. The risk of ectopic pregnancy after tubal sterilization. US Collaborative Review of Sterilization Working Group. N. Engl. J. Med. 336(11), 762-767 (1997).
94. Lete I, del Carme Cuesta M, Marín JM, Martínez M, Bermejo A, Arina R. Acceptability of the levonorgestrel intrauterine system in the long-term treatment of heavy menstrual bleeding: how many women choose to use a second device? Eur. J. Obstet. Gynecol. Reprod. Biol. 154(1), 67-70 (2011).
95. Bakken IJ, Skjeldestad FE, Schøyen U, Husby MG. Strong decline in female sterilization rates in Norway after the introduction of a new copayment system: a registry based study. BMC Womens. Health 7, 12 (2007).
96. Trussell J. Contraceptive Efficacy, in Contraception Technology. Ardent Media, NY, USA (2007).
97. Evans S. The 'baby box' returns to Europe. www.bbc.co.uk/news/magazine- 18585020
98. The Club of Rome. www.clubofrome.org
99. History of migration to Australia. www.migrationheritage.nsw.gov.au
100. International Conference on Population and Development Beyond 2014. www.icpdbeyond2014.org
101. NHS information centre. www.ic.nhs.uk
102. The Australian Longitudinal Study on Women's Health; 2009 report. www.alswh.org.au
103. Pharmaceuticals Benefits Scheme. www.pbs.gov.au
104. Benigno A. Philippine contraception law. www.bbc.co.uk/news/world-asia- 20863691